A Novel Pregelatinized Starch as a Sustained-Release Matrix Excipient - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

A Novel Pregelatinized Starch as a Sustained-Release Matrix Excipient
The authors examine the use of a novel highly functional pregelatinized starch as a controlled-release matrix excipient.


Pharmaceutical Technology


Hydrophilic gel-forming matrix systems are widely used in oral controlled-release dosage forms. Hydrophilic polymer hydrates form a viscous gel layer around the tablet surface, and drug release is controlled in a sustained manner by diffusion through a gel layer and the erosion of the gel (1). Drug solubility, however, greatly affects the rate of diffusion and erosion. It is especially difficult to control the release rate of highly water-soluble and insoluble drugs (2–4). Moreover, various gastrointestinal factors such as ionic strength and mechanical destructive force also affect the drug-release rate (5–8). To solve these problems or predict these influences, many studies have examined factors affecting drug release.


Figure 1 (All figures are courtesy of the authors.)
In this study, a highly functional pregelatinized starch (HS) was investigated as the potential basis for developing a hydrophilic matrix system for sustained release (9). The influence of drug solubility and external factors such as ionic strength, mechanical force, and accelerated storage conditions on the drug-release rate was evaluated. In addition, the effect of polyethylene glycol (PEG) on drug-release profiles was investigated to obtain zero-order release profiles.


Table 1
HS was prepared by controlled thermal pregelatinization of potato starch and a spray-drying technique. It is compatible with the National Formulary, European Pharmacopoeia, and Japanese Pharmaceutical Excipients. The properties of HS are shown in Table I. HS has different properties from conventional pregelatinized starches and conventional hydrophilic gel-matrix excipients because of its high viscosity and insoluble element in dissolution media (see Figure 1).

Experimental methods

Materials. Model drugs. Ethenzamide (ETZ), acetaminophen (APAP), and sodium salicylic acid (SSA) were used as model drugs and may be characterized as water-insoluble, moderately water-soluble, and highly water-soluble drugs, respectively. All drugs were purchased from Yoshitomi Pharmaceutical (Tokyo).

Matrix excipients. HS was prepared by Asahi Kasei Chemicals (Tokyo). Hydroxypropyl methylcellulose [(HPMC) Metolose 90SH-100SR, Metolose 90SH-4000SR, Metolose 10000SR] was purchased from Shin-Etsu Chemical (Tokyo).

Other excipients. Partially pregelatinized corn starch (Starch 1500) was purchased from Colorcon (West Point, PA). Fully pregelatinized corn starch (Amycol C) and fully pregelatinized potato starch (Amycol HF) were purchased from Nippon Starch Chemical (Osaka, Japan). Microcrystalline cellulose (MCC), Ceolus KG-802, was manufactured by Asahi Kasei Chemicals. PEG (Macrogol 6000) was supplied by Sanyo Chemical (Kyoto, Japan). Sorbitol (Sorbitol SP) was purchased from Kowa Pharmaceutical (Nagoya, Japan).

Evaluation of properties of modified starches and HPMC. Average particle diameter. Measurement samples of 5 g were sieved for 5 min using an air-jet JIS sieve of 20, 38, 75, and 150 m-mesh. The weight percent remaining on each sieve after sieving was calculated, and the particle diameter was calculated as the cumulative weight percent of 50%.

Water-soluble content. Sample dispersions of 1% were prepared at 20 C and were centrifuged for 15 min at 5000 G. The supernatant was dried at 105 C until a constant weight was reached. The dry weight was defined as the amount of soluble content and was expressed as a percentage of the initial weight of the samples.

Viscosity. The viscosity of 2% sample dispersions was determined at 25 C with a rotary viscometer (TVB-10, Toki Sangyo, Tokyo) using an M1 body.

Preparation of matrix tabletsA model drug, a matrix excipient, and other excipients were physically admixed. The mixtures of 180 mg were compressed using an 8.0-mm diameter round-faced punch at compression pressure of 60 MPa.

Drug-release study. The dissolution tests were carried out at 37 C 0.5 C using a USP Type 1 apparatus or a USP Type 2 apparatus rotating from 50 to 200 rpm. The test media consisted of 900 mL of second fluid of the Japanese Pharmacopoeia (14th edition) (JP-2, pH 6.8, and ionic strength 0.14 M) and McIlvaine buffer (pH 7.2 and ionic strength 0.39 M).

Stability test under accelerated conditions. Dissolution profiles and the yellowness index (YI) of HS and HPMC matrix tablets were evaluated after storage at 40 C and 75% relative humidity (RH) in sealed glass bottles, and at 60 C in polyamine–polyethylene bags. The YI was measured by a spectrophotometer (SE200, Nippon Denshoku, Tokyo).


ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
Which of the following business challenge poses the greatest threat to your company?
Building a sustainable pipeline of products
Attracting a skilled workforce
Obtaining/maintaining adequate financing
Regulatory compliance
Building a sustainable pipeline of products
24%
Attracting a skilled workforce
30%
Obtaining/maintaining adequate financing
15%
Regulatory compliance
30%
View Results
Eric Langer Outsourcing Outlook Eric LangerBiopharma Outsourcing Activities Update
Cynthia Challener, PhD Ingredients Insider Cynthia Challener, PhDAppropriate Process Design Critical for Commercial Manufacture of Highly Potent APIs
Jill Wechsler Regulatory Watch Jill Wechsler FDA and Manufacturers Seek a More Secure Drug Supply Chain
Sean Milmo European Regulatory WatcchSean MilmoQuality by Design?Bridging the Gap between Concept and Implementation
Medicare Payment Data Raises Questions About Drug Costs
FDA Wants You!
A New Strategy to Tackle Antibiotic Resistance
Drug-Diagnostic Development Stymied by Payer Concerns
Obama Administration Halts Attack on Medicare Drug Plans
Source: Pharmaceutical Technology,
Click here